Is Wegovy an Injection? Understanding the Role of Semaglutide in Weight Loss

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy is a prescription injectable medication approved by the FDA that contains semaglutide, a synthetic hormone that mimics glucagon-like peptide-1 (GLP-1). Clinical trials demonstrate that patients using semaglutide lose an average of 15 percent of their body weight over 68 weeks. PlexusDx provides access to compounded semaglutide injections through licensed 503A pharmacies, offering the same active ingredient as Wegovy without the brand-name price tag.

How Semaglutide Injections Work for Weight Loss

Semaglutide functions as a GLP-1 receptor agonist, a class of medication that signals your brain's appetite control centers to reduce hunger and increase feelings of fullness. When you inject semaglutide once per week, it slows stomach emptying and promotes sustained satiety, meaning you naturally eat less without constant willpower battles. Research shows that patients following a semaglutide injection protocol experience significant reductions in cravings and food noise within the first two to four weeks of treatment.

The medication also improves blood sugar regulation and supports metabolic health beyond simple calorie restriction. Unlike crash diets that slow metabolism, semaglutide helps preserve lean muscle mass while your body burns stored fat more efficiently. This dual mechanism—appetite suppression plus metabolic improvement—explains why injection therapy produces more durable results than diet and exercise alone for many patients.

Wegovy vs. Compounded Semaglutide: What You Need to Know

Wegovy and compounded semaglutide injections contain the identical active pharmaceutical ingredient, but they differ significantly in cost, accessibility, and supply reliability. Wegovy is manufactured by Novo Nordisk and typically costs $800 to $1,100 per month through retail pharmacies, often with insurance denials or prior authorization delays. PlexusDx partners with licensed 503A compounding pharmacies that prepare semaglutide injections fresh, delivering the same clinical efficacy at a fixed price starting at $149 per month—no membership fees, no insurance required.

Both options require a prescription from a licensed healthcare provider and work identically within your body once injected. The key difference is accessibility: compounded semaglutide through PlexusDx reaches all 50 states, accepts HSA and FSA funds, and eliminates the insurance bureaucracy that leaves many patients waiting months for brand-name approval. Your dose may need to go up over time as your body adapts, but your price remains fixed.

The Injection Protocol: Dosing and Administration

Semaglutide injections follow a standardized dose escalation protocol designed to minimize side effects while maximizing weight loss results. Most patients begin at 0.25 milligrams once weekly, then increase by 0.25 milligrams every four weeks until reaching their therapeutic dose, typically between 1.0 and 2.4 milligrams per week. This gradual titration allows your gastrointestinal system to adapt and reduces nausea, which is the most commonly reported early side effect.

You administer each injection subcutaneously—just under the skin—using a pre-filled pen that you can inject at home in the thigh, abdomen, or upper arm. The injection takes only seconds and causes minimal discomfort because the needle is very fine. Most patients report that after two to three injections, any injection anxiety diminishes significantly, and the weekly routine becomes automatic.

Genetic Testing to Personalize Your Semaglutide Response

Not every patient responds identically to semaglutide, and some individuals achieve faster or more dramatic weight loss depending on their genetic makeup. PlexusDx offers the Precision Peptide Genetic Test, a personalized assessment that examines your genetic variants across 14 metabolic pathways, including key markers like GLP1R rs6923761 and GIPR rs1800437 that influence how your body processes GLP-1 medications. This test maps 150+ genetic insights about your peptide response, helping your healthcare provider optimize your dose and medication selection from day one.

The genetic test is available for $99 as an add-on starting your second month of treatment, and results arrive within two weeks. Patients with specific genetic profiles may benefit more from compounded semaglutide than from combination therapies, or may require slightly higher doses to achieve their weight loss goals. This precision approach eliminates months of trial-and-error dosing.

Side Effects and Safety Monitoring

The most common side effects of semaglutide injections are gastrointestinal, particularly nausea, constipation, and reduced appetite during the first few weeks of therapy. These effects typically subside as your body adapts, usually within four to six weeks, though some patients experience mild GI symptoms throughout treatment. Staying well-hydrated, eating smaller meals, and increasing fiber intake gradually help minimize these symptoms without stopping medication.

Serious side effects are rare but require immediate attention: severe abdominal pain, signs of pancreatitis (upper left belly pain with vomiting), or rapid heart rate lasting more than a few minutes warrant contacting your healthcare provider. Because semaglutide slows digestion, patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2 should not use this medication. PlexusDx compounded medications undergo rigorous quality controls from licensed 503A pharmacies to ensure purity and potency at every dose level.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is semaglutide injection the same thing as Wegovy?

Yes, Wegovy and compounded semaglutide injections contain the identical active ingredient and work the same way in your body. The difference is cost and access: Wegovy is a brand-name product costing $800–$1,100 monthly, while PlexusDx compounded semaglutide starts at $149 per month from licensed 503A pharmacies serving all 50 states.

How much weight can I expect to lose on semaglutide injections?

Clinical trials show average weight loss of 15 percent of body weight over 68 weeks with semaglutide injections. Individual results vary based on dose, adherence, diet, and exercise habits. PlexusDx's Precision Peptide Genetic Test can reveal your genetic response potential, helping predict your likely weight loss trajectory.

Do I need insurance to start semaglutide through PlexusDx?

No. PlexusDx serves all 50 states with no insurance requirement, no membership fees, and no prior authorization delays. Your monthly price starts at $149 and remains flat regardless of dose escalation. HSA and FSA funds are accepted for payment.

What if I experience nausea from semaglutide injections?

Nausea is the most common early side effect and typically resolves within 4–6 weeks as your body adapts. Slow your dose escalation, eat smaller meals, increase hydration, and add fiber gradually to your diet. If nausea persists beyond six weeks or is severe, contact your healthcare provider immediately.

Can genetic testing help me choose between semaglutide and tirzepatide?

Absolutely. PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes across 14 pathways to reveal whether you respond better to GLP-1 alone (semaglutide) or dual GLP-1/GIP therapy (tirzepatide). This $99 test eliminates guesswork after your first month of treatment.

Related Reading

• Wegovy For Weight Loss 2
• Semaglutide For Weight Loss 2
• Wegovy Weight Loss Pills
• Semaglutide Tablets For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.